← back to search

Katya Moniz

Massachusetts Institute of Technology · US
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and Gut microbiota and health.
h-index
12
citations
3,207
works
15
NIH funding
primary concept
Biology
email

Recent publications

Metrics to relate COVID-19 wastewater data to clinical testing dynamics
Water Research 2022cited by 119position: middledoi
An omics-based framework for assessing the health risk of antimicrobial resistance genes
Nature Communications 2021cited by 824position: middledoi
Elevated rates of horizontal gene transfer in the industrialized human microbiome
Cell 2021cited by 356position: middledoi
SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases
The Science of The Total Environment 2021cited by 302position: middledoi
Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020
Water Research 2021cited by 179position: middledoi
Quantitative SARS-CoV-2 Alpha Variant B.1.1.7 Tracking in Wastewater by Allele-Specific RT-qPCR
Environmental Science & Technology Letters 2021cited by 87position: middledoi
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases
mSystems 2020cited by 875position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric J. Alm · Amgen (United States)5 papers (2020–2022)Xiaoqiong Gu · National University of Singapore4 papers (2020–2022)William P. Hanage · Harvard University4 papers (2020–2022)Fuqing Wu · Massachusetts Institute of Technology4 papers (2020–2022)Janelle R. Thompson · Massachusetts Institute of Technology4 papers (2020–2022) · 4 papers (2020–2022)Federica Armas · National University of Singapore4 papers (2020–2022)Claire Duvallet · Massachusetts Institute of Technology4 papers (2020–2022)Mariana Matus · Massachusetts Institute of Technology4 papers (2020–2022)Amy Xiao · Boston University4 papers (2020–2022)Wei Lin Lee · National University of Singapore4 papers (2020–2022)Timothy B. Erickson · University of Illinois Chicago3 papers (2020–2022)Noriko Endo · Massachusetts Institute of Technology3 papers (2020–2022) · 3 papers (2021–2022)Jianbo Zhang · Massachusetts Institute of Technology3 papers (2020–2022) · 2 papers (2021–2022)Mary Bushman · Center for Disease Dynamics, Economics & Policy2 papers (2021–2022)Mathilde Poyet · Université Claude Bernard Lyon 12 papers (2020–2021)Franciscus Chandra · University of California, Los Angeles2 papers (2021–2022)Maxim Imakaev · University of Massachusetts Chan Medical School2 papers (2021–2022)